Novartis Reaches Deal With Watson For Nicotine Replacement Products
This article was originally published in The Tan Sheet
Executive Summary
Watson Pharmaceuticals is expanding the over-the-counter sales base for its smoking cessation line through a partnership with Novartis Consumer Health